Apex Biotechnology Corp Cash Flow Quality Index
Apex Biotechnology Corp cash flow quality index. Apex Biotechnology Corp (1733) has a Cash Flow Quality Index of 0.18x as of September 2025. Operating cash flow of NT$5.19 Million is below net income of NT$29.21 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore debt repayment capacity of Apex Biotechnology Corp to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Apex Biotechnology Corp (2002–2024)
Cash flow quality index of Apex Biotechnology Corp from 2002 to 2024. Historical Cash Flow Quality Index for Apex Biotechnology Corp across 22 annual periods. Values consistently above 1.0x indicate high-quality earnings. See 1733 equity financing ratio to measure how much of total assets are equity-financed.
Apex Biotechnology Corp Cash Flow Quality Index by Year (2002–2024)
Apex Biotechnology Corp cash flow quality index by year from 2002 to 2024. Year-by-year earnings quality comparison for Apex Biotechnology Corp. For the full cash flow conversion analysis, see cash efficiency ratio of Apex Biotechnology Corp.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.15x | NT$328.67 Million | NT$153.13 Million | ▲ +31.3% |
| 2023 | 1.63x | NT$230.39 Million | NT$140.96 Million | ▲ +1125.5% |
| 2022 | 0.13x | NT$26.62 Million | NT$199.57 Million | ▼ -86.3% |
| 2021 | 0.97x | NT$179.87 Million | NT$184.94 Million | ▼ -61.7% |
| 2020 | 2.54x | NT$280.60 Million | NT$110.61 Million | ▼ -10.6% |
| 2019 | 2.84x | NT$462.52 Million | NT$162.94 Million | ▲ +577.8% |
| 2018 | 0.42x | NT$67.57 Million | NT$161.34 Million | ▼ -33.8% |
| 2017 | 0.63x | NT$70.83 Million | NT$111.97 Million | ▼ -88.9% |
| 2016 | 5.72x | NT$298.06 Million | NT$52.09 Million | ▲ +277.3% |
| 2015 | 1.52x | NT$472.15 Million | NT$311.29 Million | ▲ +80.8% |
| 2014 | 0.84x | NT$267.60 Million | NT$318.94 Million | ▼ -26.2% |
| 2013 | 1.14x | NT$484.77 Million | NT$426.38 Million | ▲ +16.5% |
| 2012 | 0.98x | NT$509.67 Million | NT$522.45 Million | ▲ +87.9% |
| 2011 | 0.52x | NT$273.45 Million | NT$526.62 Million | ▼ -49.4% |
| 2010 | 1.03x | NT$465.59 Million | NT$453.95 Million | ▼ -14.4% |
| 2009 | 1.20x | NT$391.29 Million | NT$326.48 Million | ▲ +13.6% |
| 2008 | 1.06x | NT$299.96 Million | NT$284.29 Million | ▲ +16.5% |
| 2007 | 0.91x | NT$364.62 Million | NT$402.53 Million | ▼ -24.2% |
| 2006 | 1.19x | NT$363.71 Million | NT$304.41 Million | ▼ -9.5% |
| 2004 | 1.32x | NT$218.54 Million | NT$165.49 Million | ▼ -29.4% |
| 2003 | 1.87x | NT$302.25 Million | NT$161.60 Million | ▲ +137.0% |
| 2002 | 0.79x | NT$79.49 Million | NT$100.74 Million | — |